POLBF (Poolbeg Pharma) Total Assets: $13.31 Mil (As of Dec. 2025)


What is Poolbeg Pharma Total Assets?

Poolbeg Pharma POLBF Total Assets is $13.31 Mil as of Dec. 2025. The stock has 1 warning sign investors should review.

Poolbeg Pharma's Total Assets for the quarter that ended in Dec. 2025 was $13.31 Mil.

During the past 12 months, Poolbeg Pharma's average Total Assets Growth Rate was -8.00% per year. During the past 3 years, the average Total Assets Growth Rate was -10.40% per year.

During the past 5 years, Poolbeg Pharma's highest 3-Year average Total Assets Growth Rate was 5.40%. The lowest was -10.40%. And the median was -2.50%.

Total Assets is connected with ROA %. Poolbeg Pharma's annualized ROA % for the quarter that ended in Dec. 2025 was -62.60%. Total Assets is also linked to Revenue through Asset Turnover. Poolbeg Pharma's Asset Turnover for the quarter that ended in Dec. 2025 was 0.00.

Poolbeg Pharma  (OTCPK:POLBF) Total Assets Explanation

Total Assets is connected with ROA %.

Poolbeg Pharma's annualized ROA % for the quarter that ended in Dec. 2025 is

ROA %=Net Income (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=-9.416/( (16.772+13.309)/ 2 )
=-9.416/15.0405
=-62.60 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Poolbeg Pharma's Asset Turnover for the quarter that ended in Dec. 2025 is

Asset Turnover
=Revenue (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=0/( (16.772+13.309)/ 2 )
=0/15.0405
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Poolbeg Pharma Total Assets Related Terms

Poolbeg Pharma Total Assets Historical Data

* Premium members only.

The historical data trend for Poolbeg Pharma's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Poolbeg Pharma Total Assets Chart

Poolbeg Pharma Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Total Assets
30.61 23.50 19.53 12.95 13.31

Poolbeg Pharma Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Assets Get a 7-Day Free Trial Premium Member Only 19.53 16.55 12.95 16.77 13.31

Poolbeg Pharma Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Poolbeg Pharma's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=11.514+1.795
=13.31

Poolbeg Pharma's Total Assets for the quarter that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (Q: Dec. 2025 )+Total Liabilities (Q: Dec. 2025 )
=11.514+1.795
=13.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $13.31 Mil mean?
Poolbeg Pharma (POLBF) has a Total Assets of $13.31 Mil as of Dec. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on Poolbeg Pharma and its competitors.
Is Poolbeg Pharma's Total Assets too high?
Poolbeg Pharma's current Total Assets is $13.31 Mil.
How does Poolbeg Pharma's Total Assets compare to VRTX and REGN?
Poolbeg Pharma's Total Assets of $13.31 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Poolbeg Pharma and its competitors. Poolbeg Pharma's current Total Assets is $13.31 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Poolbeg Pharma stock overvalued right now?
Poolbeg Pharma (POLBF) has a current Total Assets of $13.31 Mil. The current Total Assets is $13.31 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Poolbeg Pharma (POLBF), the current Total Assets is $13.31 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Poolbeg Pharma Business Description

Other Exchanges POLB:UK7JN:Germany
Address 20 St. Andrew Street, The Clubhouse Holborn, London, GBR, EC4A 3AG
Poolbeg Pharma PLC is a clinical-stage biopharmaceutical company with a core focus on transforming the cancer immunotherapy field. The Company's main asset, POLB 001, has the potential to expand administration of cancer immunotherapies from centralised specialist cancer centres into community hospitals by making the treatments safer through the prevention of the life-threatening side effect, Cytokine Release Syndrome (CRS). The group is also advancing the development of a patient-friendly therapy for obesity with an oral encapsulated GLP-1, offering a differentiated approach within one of the world's markets. It is focused on partnering its high-value programmes that are targeting large markets and addressing critical unmet medical needs.